Larissa Pereira Alves

Dr. Larissa Pereira Alves

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Acta Tropica
Verified
Journal Article
Closed access
LFLeslie Raphael Ferraz
Leslie Raphael Ferraz
LSLaysa Creusa Paes Barreto Barros Silva
Laysa Creusa Paes Barreto Barros Silva
MSMyla Lôbo de Souza
Myla Lôbo de Souza
LALarissa Pereira Alves
Larissa Pereira Alves
VSVictor de Albuquerque Wanderley Sales
Victor de Albuquerque Wanderley Sales
PRPedro José Rolim-Neto
Pedro José Rolim-Neto

2 July 2019 in Polymers
Verified
Journal Article
Open access
PDF file
AAAmaro César Lima de Assis Amaro
Amaro César Lima de Assis Amaro
LALarissa Pereira Alves
Larissa Pereira Alves
JMJoão Paulo Tavares Malheiro
João Paulo Tavares Malheiro
ABAlana Rafaela Albuquerque Barros
Alana Rafaela Albuquerque Barros
EPEdvânia Emannuelle Pinheiro-Santos
Edvânia Emannuelle Pinheiro-Santos
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
Cellulose is among the top 5 excipients used in the pharmaceutical industry. It has been considered one of the main diluents used in conventional and modern dosage forms. Therefore, different raw materials of plant origin have been evaluated as potential alternative sources of cellulose. In this context, Opuntia ficus-indica L. Miller (palma forrageira), a plant of the cactus family that has physiological mechanisms that provide greater productivity with reduced water requirements, is an interesting and unexplored alternative for extracting cellulose. By using this source, we aim to decrease the extraction stages and increase the yields, which might result in a decreased cost for the industry and consequently for the consumer. The aim of this work was to investigate the use of Opuntia ficus-indica L. Miller as a new source for cellulose extraction, therefore providing an efficient, straight forward and low-cost method of cellulose II production. The extraction method is based on the oxidation of the lignins. The obtained cellulose was identified and characterized by spectroscopic methods (FTIR and NMR), X-ray diffraction, thermal analysis (TGA-DTG and DSC) and scanning electron microscopy. The results confirmed the identity of cellulose and its fibrous nature, which are promising characteristics for its use in the industry and a reasonable substrate for chemical modifications for the synthesis of cellulose II derivatives with different physicochemical properties that might be used in the production of drug delivery systems and biomaterials.

31 March 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VMVandiara Martins Moreira
Vandiara Martins Moreira
JLJoandra Maísa Silva Leite
Joandra Maísa Silva Leite
KMKaline de Araújo Medeiros
Kaline de Araújo Medeiros
KAKaroll Moangella Andrade de Assis
Karoll Moangella Andrade de Assis
JBJoyce Cordeiro Borges
Joyce Cordeiro Borges
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
This study aimed to develop films of chitosan (CSF) associated with pentoxifylline (PTX) for healing cutaneous wounds. These films were prepared at two concentrations, F1 (2.0 mg/mL) and F2 (4.0 mg/mL), and the interactions between the materials, structural characteristics, in vitro release, and morphometric aspects of skin wounds in vivo were evaluated. The formation of the CSF film with acetic acid modifies the polymeric structure, and the PTX demonstrates interaction with the CSF, in a semi-crystalline structure, for all concentrations. The release for all films was proportional to the concentration, with two phases: a fast one of ≤2 h and a slow one of >2 h, releasing 82.72 and 88.46% of the drug after 72 h, being governed by the Fickian diffusion mechanism. The wounds of the mice demonstrate a reduction of up to 60% in the area on day 2 for F2 when compared to CSF, F1, and positive control, and this characteristic of faster healing speed for F2 continues until the ninth day with wound reduction of 85%, 82%, and 90% for CSF, F1, and F2, respectively. Therefore, the combination of CSF and PTX is effective in their formation and incorporation, demonstrating that a higher concentration of PTX accelerates skin-wound reduction.

1 February 2022 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MSMyla Lôbo de Souza
Myla Lôbo de Souza
VSVictor de Albuquerque Wanderley Sales
Victor de Albuquerque Wanderley Sales
LALarissa Pereira Alves
Larissa Pereira Alves
WSWidson Michael dos Santos
Widson Michael dos Santos
LFLeslie Raphael Ferraz
Leslie Raphael Ferraz
PNPedro José Rolim Neto
Pedro José Rolim Neto
Background: The oral route is the most frequently used and the most convenient route of drug administration since it has several advantages, such as ease of use, patient compliance, and better costeffectiveness. However, physicochemical and biopharmaceutical limitations of various active pharmaceutical ingredients (API) hinder suitability for this route, including degradation in the gastrointestinal tract, low intestinal permeability, and low bioavailability. To overcome these problems, while maintaining therapeutic efficacy, polymeric nanoparticles have attracted considerable attention for their ability to increase drug solubility, promote the controlled release, and improve stability. In addition, the functionalization of nanocarriers can increase uptake and accumulation at the target site of action, and intestinal absorption, making it possible to obtain more viable, safe and efficient treatments for oral administration. Objective: This systematic review aimed to seek recent advances in the literature on the use of polymeric nanoparticles functionalization to increase intestinal permeability of APIs that are intended for oral administration. Method: Two bibliographic databases were consulted (PubMed and ScienceDirect). The selected publications and the writing of this systematic review were based on the guidelines mentioned in the PRISMA statement. Results: Out of a total of 3036 studies, 22 studies were included in this article based on our eligibility criteria. The results were consistent for the application of nanoparticle functionalization to increase intestinal permeability. Conclusion: The functionalized polymeric nanoparticles can be considered as carrier systems that improve the intestinal permeability and bioavailability of APIs, with the potential to result, in the future, in the development of oral medicines.

2 July 2024 in Polymers
Verified
Journal Article
Open access
PDF file
LALarissa Pereira Alves
Larissa Pereira Alves
KOKevin da Silva Oliveira
Kevin da Silva Oliveira
ASAna Cláudia Gonçalves dos Santos
Ana Cláudia Gonçalves dos Santos
DMDemis Melo
Demis Melo
LMLívia Maria Coelho de Carvalho Moreira
Lívia Maria Coelho de Carvalho Moreira
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
Simvastatin (SIM) is widely prescribed to treat hyperlipidemia, despite its limitations, such as a short half-life and low oral bioavailability. To overcome these drawbacks, the development of a controlled-release formulation is desirable. This study aims to develop a microparticulate system based on cellulose acetate (ACT) obtained from Agave sisalana Perrine to promote a controlled SIM release. SIM-loaded microparticles (SMP) were prepared using the solvent emulsification-evaporation method. Several parameters were evaluated, including particle size, surface charge, morphology, encapsulation efficiency, thermochemical characteristics, crystallinity, and in vitro release profile. ACT exhibited favorable flow properties after acetylation, with a degree of substitution values superior to 2.5, as confirmed by both the chemical route and H-NMR, indicating the formation of cellulose triacetate. The obtained SMP were spherical with an average size ranging from 1842 to 1857 nm, a zeta potential of −4.45 mV, and a high SIM incorporation efficiency (98%). Thermal and XRD analyses revealed that SIM was homogeneously dispersed into the polymeric matrix in its amorphous state. In vitro studies using dialysis bags revealed that the controlled SIM release from microparticles was higher under simulated intestinal conditions and followed the Higuchi kinetic model. Our results suggest that ACT-based microparticles are a promising system for SIM delivery, which can improve its bioavailability, and result in better patient compliance.

5 October 2022 in Current Pharmaceutical Analysis
Verified
Journal Article
Closed access
PDF file
JLJoandra Maísa Silva Leite
Joandra Maísa Silva Leite
CACamila Beatriz Barros Araújo
Camila Beatriz Barros Araújo
LALarissa Pereira Alves
Larissa Pereira Alves
MPMilena Raissa Bezerra Pereira
Milena Raissa Bezerra Pereira
GGGabryella Garcia Guedes
Gabryella Garcia Guedes
BDBolívar Ponciano Goulart de Lima Damasceno
Bolívar Ponciano Goulart de Lima Damasceno
Background: Dexamethasone (DEXA) is a potent synthetic corticosteroid derived from the cyclopentanoperhydrophenanthrene nucleus known for its anti-inflammatory and immunosuppressive activities. Due to its therapeutic effects, several analytical methods have been used for its quantitative determination and physicochemical characterization, as well as for the evaluation of pharmacological and toxicological properties. Objective: This review aimed to describe the principles and methods commonly used to identify and quantify DEXA in drug delivery systems and biological samples. The methods herein discussed are high-performance liquid chromatography, nuclear magnetic resonance, x-ray diffraction, Fourier-transform infrared spectroscopy, differential scanning calorimetry, ultravioletvisible spectrophotometry and thin layer chromatography. Conclusion: This review provided a wide variety of analytical methods that can be used for the quantification and identification of drugs, providing scientists with great support during the development of scientific research, as well as ensuring the quality of the manufacturing processes as well as the resulting products. Therefore, the use of such analytical methods has become critical throughout the process of developing pharmaceutical formulations containing DEXA.